These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8565990)

  • 41. A new plasmidic cefotaximase from patients infected with Salmonella typhimurium.
    Bauernfeind A; Casellas JM; Goldberg M; Holley M; Jungwirth R; Mangold P; Röhnisch T; Schweighart S; Wilhelm R
    Infection; 1992; 20(3):158-63. PubMed ID: 1644493
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [In vitro antibacterial activity of a new cephalosporin: cefpirome (HR 810). Comparison with ceftriaxone, cefotaxime, latamoxef and ceftazidime].
    Le Noc P; Bryskier A; Le Noc D
    Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):567-71. PubMed ID: 3534744
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Emergence of blaCTX-M-15, blaTEM-169 and blaPER-1 extended-spectrum β-lactamase genes among different Salmonella enterica serovars from human faecal samples.
    Tajbakhsh M; Avini MY; Alikhajeh J; Tajeddin E; Rahbar M; Eslami P; Alebouyeh M; Zali MR
    Infect Dis (Lond); 2016 Jul; 48(7):550-6. PubMed ID: 27117981
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Characteristics of drug resistance and molecular typing research for Salmonella Enteritidis isolated in Henan province from 2011 to 2013].
    Zhao J; Zhang Y; Xie Z; Pan J; Su J; Mu Y; Huang X; Zhang B; Xia S
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Mar; 50(3):261-5. PubMed ID: 26957246
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Antibacterial activity in vitro and beta-lactamase stability of the new cephalosporin HR 810 in comparison with five other cephalosporins and two aminoglycosides.
    Seibert G; Limbert M; Winkler I; Dick T
    Infection; 1983; 11(5):275-9. PubMed ID: 6315595
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Third-generation cephalosporin resistance in Shigella sonnei, Argentina.
    Radice M; Gonzéález C; Power P; Vidal MC; Gutkind G
    Emerg Infect Dis; 2001; 7(3):442-3. PubMed ID: 11384523
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of experimental endocarditis due to ampicillin-susceptible or ampicillin-resistant Salmonella enteritidis.
    Fernández Guerrero ML; Torres Perea R; Verdejo Morcillo C; Fernández Roblas R; de Górgolas M
    Antimicrob Agents Chemother; 1996 Jul; 40(7):1589-93. PubMed ID: 8807045
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Emergence of extended-spectrum beta-lactamases and AmpC-type beta-lactamases in human Salmonella isolated in Spain from 2001 to 2005.
    González-Sanz R; Herrera-León S; de la Fuente M; Arroyo M; Echeita MA
    J Antimicrob Chemother; 2009 Dec; 64(6):1181-6. PubMed ID: 19815633
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [A nosocomial epidemic of Salmonella mbandaka which produces various broad spectrum beta-lactamases: preliminary results].
    Rahal K; Reghal A
    Med Trop (Mars); 1994; 54(3):227-30. PubMed ID: 7885201
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Salmonella enteritidis: an unusual meningitis agent in an adult patient].
    Metan G; Alp E; Eşel D; Aygen B; Sümerkan B
    Mikrobiyol Bul; 2005 Oct; 39(4):509-12. PubMed ID: 16544553
    [TBL] [Abstract][Full Text] [Related]  

  • 51. High prevalence of ceftriaxone resistance among invasive Salmonella enterica serotype Choleraesuis isolates in Thailand: The emergence and increase of CTX-M-55 in ciprofloxacin-resistant S. Choleraesuis isolates.
    Luk-In S; Chatsuwan T; Pulsrikarn C; Bangtrakulnonth A; Rirerm U; Kulwichit W
    Int J Med Microbiol; 2018 Jun; 308(4):447-453. PubMed ID: 29605531
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antimicrobial resistance and prevalence of extended spectrum beta-lactamase among clinical isolates of gram-negative bacteria in Riyadh.
    El-Karsh T; Tawfik AF; Al-Shammary F; Al-Salah S; Kambal AM; Shibl AM
    J Chemother; 1995 Dec; 7(6):509-14. PubMed ID: 8667034
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular epidemiology of ceftazidime resistant Enterobacteriaceae from patients on a paediatric oncology ward.
    Hibbert-Rogers LC; Heritage J; Gascoyne-Binzi DM; Hawkey PM; Todd N; Lewis IJ; Bailey C
    J Antimicrob Chemother; 1995 Jul; 36(1):65-82. PubMed ID: 8537285
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ceftriaxone-resistant Salmonella in the United States.
    Herikstad H; Hayes PS; Hogan J; Floyd P; Snyder L; Angulo FJ
    Pediatr Infect Dis J; 1997 Sep; 16(9):904-5. PubMed ID: 9306487
    [No Abstract]   [Full Text] [Related]  

  • 55. First human isolate of Salmonella enterica serotype Enteritidis harboring blaCTX-M-14 in South America.
    Bado I; García-Fulgueiras V; Cordeiro NF; Betancor L; Caiata L; Seija V; Robino L; Algorta G; Chabalgoity JA; Ayala JA; Gutkind GO; Vignoli R
    Antimicrob Agents Chemother; 2012 Apr; 56(4):2132-4. PubMed ID: 22290976
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterization of a plasmid coding for resistance to broad-spectrum cephalosporins in Salmonella typhimurium.
    Garbarg-Chenon A; Vu Thien H; Labia R; Ben-Yaghlane H; Godard V; Deny P; Bricout F; Nicolas JC
    Drugs Exp Clin Res; 1989; 15(4):145-50. PubMed ID: 2673714
    [TBL] [Abstract][Full Text] [Related]  

  • 57. OHIO-1 beta-lactamase mutants: Asp179Gly mutation confers resistance to ceftazidime.
    Bonomo RA; Rudin SD; Shlaes DM
    FEMS Microbiol Lett; 1997 Jul; 152(2):275-8. PubMed ID: 9231421
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility tests.
    Jones RN; Barry AL; Thornsberry C; Gerlach EH; Fuchs PC; Gavan TL; Sommers HM
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():187-211. PubMed ID: 19802985
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Novel SHV-derived extended-spectrum beta-lactamase, SHV-57, that confers resistance to ceftazidime but not cefazolin.
    Ma L; Alba J; Chang FY; Ishiguro M; Yamaguchi K; Siu LK; Ishii Y
    Antimicrob Agents Chemother; 2005 Feb; 49(2):600-5. PubMed ID: 15673739
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterization of TEM-, SHV- and AmpC-type beta-lactamases from cephalosporin-resistant Enterobacteriaceae isolated from swine.
    Rayamajhi N; Kang SG; Lee DY; Kang ML; Lee SI; Park KY; Lee HS; Yoo HS
    Int J Food Microbiol; 2008 May; 124(2):183-7. PubMed ID: 18455821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.